Baltimore Coffee & Tea Company, Inc, The – Trademark Portfolio

Entity Type: 03

Baltimore Coffee & Tea Company, Inc, The holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include BALTIMORE COFFEE 1895 and BALTIMORE COFFEE & TEA CO.. The owner is based in Timonium, MD.

9 West Aylesbury Road

Timonium, MD 21093

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Baltimore Coffee & Tea Company, Inc, The's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

30
Staple Foods (2 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Baltimore Coffee & Tea Company, Inc, The have?

Baltimore Coffee & Tea Company, Inc, The has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Baltimore Coffee & Tea Company, Inc, The file in?

Baltimore Coffee & Tea Company, Inc, The files trademarks across 1 Nice Classification class. The most active classes are Class 30 (Staple Foods). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.

What are Baltimore Coffee & Tea Company, Inc, The's most well-known trademarks?

Baltimore Coffee & Tea Company, Inc, The's registered trademark portfolio includes well-known marks such as BALTIMORE COFFEE 1895 and BALTIMORE COFFEE & TEA CO.. These are among 2 currently registered trademarks in the portfolio.

What is Baltimore Coffee & Tea Company, Inc, The's trademark registration success rate?

Baltimore Coffee & Tea Company, Inc, The has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.